Published in Vaccine on July 20, 2001
Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other. J Virol (2012) 0.85
The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires. Immunogenetics (2015) 0.78
Immunological correlates of vaccination and infection for equine herpesvirus 1. Clin Vaccine Immunol (2011) 0.76
Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach. Influenza Other Respir Viruses (2016) 0.75
Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine. Vaccine (2002) 0.75
Successful control of winter pyrexias caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage. Clin Vaccine Immunol (2014) 0.75
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec (2006) 2.10
Testing for equine arteritis virus. Vet Rec (2004) 1.96
Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol (1996) 1.96
Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI. J Gen Virol (1980) 1.84
XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol (1981) 1.58
The DNA sequence of equine herpesvirus-4. J Gen Virol (1998) 1.54
Susceptibility of ponies to infection with Streptococcus pneumoniae (capsular type 3) Equine Vet J (1994) 1.50
Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1. Equine Vet J (1992) 1.48
Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet J (2001) 1.46
Characterisation of equine influenza isolates from the 1987 epizootic in India by nucleotide sequencing of the HA1 gene. Equine Vet J (1993) 1.41
Sedation in primary dental care: an investigation in two districts of northern England. Br Dent J (1998) 1.40
Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet J (1990) 1.39
Testing for equine arteritis virus. Vet Rec (2003) 1.31
Testing for equine arteritis virus. Vet Rec (2003) 1.30
Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet J (1994) 1.23
Association between respiratory disease and bacterial and viral infections in British racehorses. J Clin Microbiol (2005) 1.23
Vaccination against equine influenza: quid novi? Vaccine (2006) 1.21
Detection of strangles carriers. Vet Rec (1998) 1.15
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995. Vet Immunol Immunopathol (1998) 1.14
Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet J (1994) 1.13
Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J (2000) 1.12
Respiratory disease in thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Vet Rec (1996) 1.10
Comparison of the physical maps of the DNAs of two cytomegalovirus strains. J Gen Virol (1983) 1.05
Development of the nitrogen-fixing and protein-synthesizing apparatus of bacteroids in pea root nodules. Biochim Biophys Acta (1979) 1.05
Equine influenza vaccine efficacy: the significance of antigenic variation. Vet Microbiol (2000) 1.05
Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J Gen Virol (1995) 1.05
Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction. Equine Vet J (1992) 1.02
Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007. J Virol (2011) 1.01
Identification and nucleotide sequence of the glycoprotein gB gene of equine herpesvirus 4. J Virol (1989) 1.01
Preliminary evaluation of diagnostic tests using horses experimentally infected with trypanosoma evansi. Vet J (2001) 1.00
The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Proc Biol Sci (2004) 1.00
Antigenic and molecular characterization of host cell-mediated variants of equine H3N8 influenza viruses. J Gen Virol (1994) 0.98
Modelling equine influenza 1: a stochastic model of within-yard epidemics. Epidemiol Infect (2002) 0.98
Optimising vaccination strategies in equine influenza. Vaccine (2003) 0.96
Characterization of the haemolytic activity of Streptococcus equi. Microb Pathog (1998) 0.96
Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect (1994) 0.96
Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet J (1976) 0.95
Mercury contamination incident. J Public Health Med (2001) 0.94
Equine influenza in the United Kingdom in 1998. Vet Rec (1999) 0.94
Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses. Equine Vet J (2005) 0.94
The nucleotide sequence of an equine herpesvirus 4 gene homologue of the herpes simplex virus 1 glycoprotein H gene. J Gen Virol (1990) 0.93
The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet Rec (1993) 0.93
Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J Virol Methods (1995) 0.93
Variation in cellular tropism between isolates of equine herpesvirus-1 in foals. Arch Virol (1982) 0.92
Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet Immunol Immunopathol (1989) 0.92
Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J Gen Virol (1994) 0.91
Diagnosis of equine infectious anaemia during the 2006 outbreak in Ireland. Vet Rec (2007) 0.89
The dental health of single male hostel dwellers in Leeds. Community Dent Health (1995) 0.88
Expression cloning of an equine T-lymphocyte glycoprotein CD2 cDNA. Structure-based analysis of conserved sequence elements. Eur J Biochem (1994) 0.88
Vectors and vector-borne diseases of horses. Vet Res Commun (2012) 0.88
Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine (2005) 0.87
Increased release of hydrogen peroxide and superoxide anion from asbestos-primed macrophages. Effect of hydrogen peroxide on the functional activity of alpha 1-protease inhibitor. Inflammation (1985) 0.87
Clinical aspects of lymphosarcoma in the horse: a clinical report of 16 cases. Equine Vet J (1983) 0.87
Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet Immunol Immunopathol (2006) 0.87
Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. J Virol Methods (1988) 0.87
The accuracy of three different heart rate meters used for studies in the exercising horse. Zentralbl Veterinarmed A (1988) 0.87
Direct sequencing of the HA gene of clinical equine H3N8 influenza virus and comparison with laboratory derived viruses. Arch Virol (1998) 0.87
Duration of circulating antibody and immunity following infection with equine influenza virus. Vet Rec (1988) 0.87
Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. Vet Rec (1995) 0.87
Variation of fiber types in the triceps brachii, longissimus dorsi, gluteus medius, and biceps femoris of horses. Am J Vet Res (1985) 0.86
Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus. Vet Rec (1984) 0.86
Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine (1994) 0.86
In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4. Res Vet Sci (2003) 0.86
Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Res (1995) 0.85
Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Vaccine (2004) 0.85
The outbreak of equine influenza in England: January 1976. Vet Rec (1977) 0.85
Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol (2003) 0.85
Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet J (2003) 0.85
Surveillance of equine influenza viruses through the RESPE network in France from November 2005 to October 2010. Equine Vet J (2013) 0.85
Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res Vet Sci (1993) 0.85
EHV1 and equine paresis. Vet Rec (1980) 0.85
Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus. J Virol Methods (2000) 0.84
The Clostridium perfringens enterotoxin from equine isolates; its characterization, sequence and role in foal diarrhoea. Epidemiol Infect (1998) 0.84
Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity. Br J Cancer (1980) 0.84
Immunomodulatory effects of mineral dust. I. Effects of intraperitoneal dust inoculation on splenic lymphocyte function and humoral immune responses in vivo. J Clin Lab Immunol (1985) 0.84
Screening of horse polyclonal antibodies with a random peptide library displayed on phage: identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus. J Virol Methods (1998) 0.84
Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic. Arch Virol (1993) 0.84
Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials. J Immunol Methods (2002) 0.83
Cellular interactions modulating host resistance to tumours. Recent Results Cancer Res (1982) 0.83
Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. Vet Microbiol (1992) 0.83
Foal diarrhoea between 1991 and 1994 in the United Kingdom associated with Clostridium perfringens, rotavirus, Strongyloides westeri and Cryptosporidium spp. Epidemiol Infect (1996) 0.83
An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1. Equine Vet J (1993) 0.82
The effects of vaccination with tissue culture-derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA). Vet Microbiol (1989) 0.82
Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol (1999) 0.82
Molecular analysis of the virulence determinants of Clostridium perfringens associated with foal diarrhoea. Vet J (1998) 0.82